Cargando…

OR08-2 Androgen Receptor- Vs Estrogen Receptor-Mediated Actions in the Development of Distinct Clinical Polycystic Ovary Syndrome (PCOS) Phenotypes

Polycystic ovary syndrome (PCOS) is a complex hormonal disorder characterised by reproductive, endocrine and metabolic abnormalities. Currently, as the origins of PCOS remain unknown, mechanism-based treatments are not feasible and management relies on treatment of symptoms. However if the underlyin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aflatounian, Ali, Edwards, Melissa, Gilchrist, Robert, Bertoldo, Michael, Ledger, William, Handelsman, David, Walters, Kirsty
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555049/ http://dx.doi.org/10.1210/js.2019-OR08-2

Ejemplares similares

SAT-018 Androgen Actions in Adipose Tissue and the Brain Are Key Mediators in the Development of Polycystic Ovary Syndrome
por: Cox, Madeleine J, et al.
Publicado: (2020)

MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
por: Rodriguez Paris, Valentina, et al.
Publicado: (2019)

Metabolic PCOS Features Are Ameliorated by Mitochondrial Uncoupler BAM15 in a PCOS Mouse Model
por: Paris, Valentina Rodriguez, et al.
Publicado: (2021)

Pathogenesis of Reproductive and Metabolic PCOS Traits in a Mouse Model
por: Rodriguez Paris, Valentina, et al.
Publicado: (2021)

MON-022 Dissecting the Interplay Between Diet and PCOS Pathology on Gut Microbiota in a PCOS Mouse Model
por: Paris, Valentina Rodriguez, et al.
Publicado: (2020)

Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?
por: Walters, Kirsty A, et al.
Publicado: (2016)

SUN-012 Role of Leptin-Receptor Expressing Cells in the Pathogenesis of Polycystic Ovary Syndrome (PCOS)
por: Cara, Alexandra, et al.
Publicado: (2020)

MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature
por: Shirin, Sonia, et al.
Publicado: (2020)

SAT365 Prevalence of Polycystic Ovary Syndrome (PCOS) in Health System and Insurer Records vs. the Prevalence in the Population: Evidence for the Significant Underdiagnosis and Undertreatment of PCOS
por: Hatoum, Sana, et al.
Publicado: (2023)

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology
por: Kazemi, Maryam, et al.
Publicado: (2019)

MON-LB9 Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS) - Person-Related 6-Month Experience Changes
por: Shirin, Sonia, et al.
Publicado: (2020)

Declining muscle NAD(+) in a hyperandrogenism PCOS mouse model: Possible role in metabolic dysregulation
por: Aflatounian, Ali, et al.
Publicado: (2022)

SAT353 Relevance of Ovarian Morphology Among Adolescents With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

OR33-1 Metabolic Inflexibility in Obese versus Lean Women with Polycystic Ovary Syndrome (PCOS): Is PCOS Status or Adiposity the Critical Factor?
por: Gebara, Nour, et al.
Publicado: (2019)

SAT388 Does Obesity Drive the Development of Polycystic Ovary Syndrome (PCOS)? An Epidemiologic Study
por: Amiri, Mina, et al.
Publicado: (2023)

OR35-02 Novel Androgen Receptor PROTAC Degrader ARV-110 Ameliorates Androgen Mediated Renal Injury in a Mouse Model of Polycystic Ovary Syndrome
por: Basnet, Jelina, et al.
Publicado: (2023)

FRI458 Rare Pathogenic Missense Variants in LMNA Identified in Women with Polycystic Ovary Syndrome (PCOS)
por: Bauer, Rosemary, et al.
Publicado: (2023)

SAT372 Obstructive Sleep Apnea (OSA) Risk Among Patients With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

PMON245 Clinical Phenotypes of Polycystic Ovary Syndrome (PCOS) in Nigerian Women: Preliminary Results of the Nigeria PCOS Epidemiology & Phenotype (Nigeria-Pep) Study
por: Balogun, Mobolanle, et al.
Publicado: (2022)

MON-234 Targeted Profiling of Plasma MicroRNAs in Women with Polycystic Ovary Syndrome (PCOS): Impact of Obesity
por: Almawi, Wassim, et al.
Publicado: (2019)

SUN-013 Cardiometabolic Profile of Brazilian Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review and Meta-Analysis
por: Marchesan, Lucas Bandeira, et al.
Publicado: (2020)

Lifestyle, Anxiety,Depression, and Clinical Profile in Women With Polycystic Ovary Syndrome: Initial Results From the Brazilian PCOS Study
por: Spritzer, Poli Mara, et al.
Publicado: (2021)

SAT381 Effect of Obesity on Androgen-induced Splenic Dysregulation in Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2023)

Estrogen Receptors in Polycystic Ovary Syndrome
por: Xu, Xue-Ling, et al.
Publicado: (2021)

MON-029 Polycystic Ovary Syndrome (PCOS) in Adolescent Girls:Toward a Simple On-Treatment Predictor of Post-Treatment Ovulation Rate
por: Ibanez, Lourdes, et al.
Publicado: (2020)

ODP642 Differences in hormonal profiles and vitamin D status depending on the insulin sensitivity status in women with polycystic ovary syndrome (PCOS).
por: Ozga-Piszczek, Katarzyna, et al.
Publicado: (2022)

SUN-019 Androgens Modulate Lipid Metabolism and Absorption in Control and Polycystic Ovary-Metabolic Syndrome Conditions
por: Vine, Donna Faye, et al.
Publicado: (2020)

MON-201 ER Stress Activated by Androgen Enhances Apoptosis of Granulosa Cells via Induction of Death Receptor 5 in PCOS
por: Azhary, Jerilee, et al.
Publicado: (2019)

The interplay between PCOS pathology and diet on gut microbiota in a mouse model
por: Rodriguez Paris, Valentina, et al.
Publicado: (2022)

MON-043 Sleep Disturbances in Women with and Without Polycystic Ovary Syndrome (PCOS) and Their Association with Lifestyle Factors (Diet, Physical Activity and Sitting Time)
por: Bennett, Christie, et al.
Publicado: (2020)

SAT363 The Prevalence And Phenotype Of Polycystic Ovary Syndrome (PCOS) In A Community-Based Population In Sub-Sahara Africa: The Nigeria-PEP Study
por: Makwe, Christian Chigozie, et al.
Publicado: (2023)

Expression of the plasminogen system in the physiological mouse ovary and in the pathological polycystic ovary syndrome (PCOS) state
por: Burchall, Genia F., et al.
Publicado: (2019)

Role of Androgen Receptor for Reconsidering the “True” Polycystic Ovarian Morphology in PCOS
por: Gao, Xue-ying, et al.
Publicado: (2020)

MON-230 Androgen-Induced Disruption of the Biological Clock: The Link between PCOS and NAFLD
por: Abudu, Aierken, et al.
Publicado: (2019)

SAT-024 Investigating Racial and Ethnic Comorbidity Patterns of Polycystic Ovary Syndrome
por: Actkins, Ky’Era, et al.
Publicado: (2020)

MON-LB038 Reduced Exercise Endurance And Skeletal Muscle Alterations In A Prenatally Androgenized Rat Model For Polycystic Ovary Syndrome
por: DeChick, Auryana, et al.
Publicado: (2019)

Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS)
por: Laven, Joop S. E.
Publicado: (2019)

Genetic Sex Effects of Polycystic Ovary Syndrome Reveal Distinct Metabolic Etiology
por: Actkins, Ky’Era, et al.
Publicado: (2021)

Reconsidering the Polycystic Ovary Syndrome (PCOS)
por: Gleicher, Norbert, et al.
Publicado: (2022)

SAT386 Constitutive Overexpression Of Microrna-93 As A Cause Of Metabolic Dysfunction And Hyperandrogenism In Polycystic Ovary Syndrome (PCOS): Evidence From A Transgenic (Mir-93+) Murine Model
por: Chen, Yen-Hao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qedbqfdh3cau8urvclmufirmfr